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After 12 years, the Hannan Crusaid Treatment 
Centre (HCTC) in Gugulethu, Cape Town 
has screened more than 10 000 women, men, 
adolescents and children for life-saving antiretro-
viral therapy (ART). While we have seen a slow 
but steady increase in the starting CD4+ count of new patients, 
the monthly inflow of new clients goes on unabated. A successful 
example of public-private partnership, this provincial clinic, 
supported by a local non-governmental organisation and initially 
funded by a UK-based charity, may provide a model for similar 
programmes within the National Health Insurance plan. Here 
we discuss the history and development of this programme, with 
a focus on lessons learnt about rolling out ART in South Africa 
more generally.
Early beginnings
The first community-based treatment at the Gugulethu Day 
Hospital was provided in 2002 by a team from the Desmond 
Tutu HIV Centre, literally working out of a biscuit box! Dr 
Catherine Orrell, Sr Felicity Cope and six counsellors opened a 
clinic on three days a week, bringing in their daily supplies each 
time in a cardboard box and having to wait for the availability 
of a consultation room. The first patients were extremely ill and 
many did not survive the first few months of ART. Shortages of 
medication meant that rationing decisions had to be made on a 
daily basis. Despite this, the team continued with enthusiasm, 
as every patient was known by name, many received regular 
home visits, and some were at times escorted to hospitals 
by our doctors or had ART hand-delivered to them while in 
hospice care.
By March 2003, the ART service was able to open full-time 
with the addition of Dr Kwezi Matoti (and his room in the 
clinic, giving a dedicated space for the service), with Sr Lulu 
Mtwisha heading Sizophila, a team of therapeutic counsellors 
who provided support for patients starting treatment. The 
first 150 carefully rationed treatment places were expanded 
to just 350, but we endeavoured to have an open-door policy 
– allowing people to attend whenever they felt they needed, 
and never turning anyone away. While the initial focus of the 
treatment programme was predominantly on the provision 
of ART in a primary healthcare setting, over time we also 
established a strong research programme that enabled us to 
better understand the HIV epidemic and the impact of our 
interventions. Much of this work has gone on to inform local, 
national and international policies and, as elsewhere in South 
Africa, this demonstrates the potential synergies that academic 
medicine can bring to strengthening healthcare delivery. 
This has included insights into ART adherence, nurse-driven 
services to step-down ART management, earlier treatment of 
HIV/tuberculosis (TB) co-infection and rapid initiation of ART 
in pregnancy.  Of note, the HCTC team helped to shape the first 
Western Province ART guidelines using the lessons learnt from 
this clinic, and these subsequently went on to inform the first 
national ART guidelines. 
Lessons learnt
Adherence, loss to follow-up 
and virological failure
A strong interest in adherence led us to design our programme 
to include three treatment-preparedness sessions and to include 
pill counts at each visit. Early adherence data were excellent 
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In 2001, the size of the problem made it very clear that ART would 
need to be delivered at primary healthcare level and money was 
sought to provide such a programme in the Nyanga District of Cape 
Town. So began a three-way partnership between the Western 
Cape Provincial Department of Health, led by Dr Fareed Abdullah, 
the Desmond Tutu HIV Foundation and CRUSAID, the UK-based 
AIDS Charity with a large endowment from Ms Katy Hannan. 
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and virological suppression (viral load (VL) 
<50 copies/ml) was noted in >90% of those 
receiving treatment at every time point in the 
first 3 years.[1] A system, initially called the ‘red 
alert’ system, was designed to identify and 
support those whose VL was unsuppressed 
(>1 000 copies/ ml) at any point after starting 
ART. This ‘red alert’ system included an extra 
adherence-focused education session, an 
increased frequency of counsellor home visits, 
the provision of pill boxes and monthly visits 
to the clinic. We showed that 75% of those who 
experienced virological breakthrough could 
re-suppress their VL after this intervention.[2] 
Based on counting tablet returns, adherence 
appears to remain high in the cohort. Adher-
ence continues to be an important focus of the 
programme and, with the introduction of TB 
treatment in the clinic in 2011, the adherence 
support system was expanded to provide 
integrated community support for HIV/TB 
co-infected patients.
Sizophila (‘we are well’) 
therapeutic counsellors
In 1999, a small band of enthusiastic women 
who had survived HIV as participants in 
our early ART clinical trials stepped forward 
requesting to help others do the same. We 
taught them all we knew about ART, called 
them ‘therapeutic counsellors’ and initially 
asked them to work in our programmes 
at Somerset and Groote Schuur hospitals 
in Cape Town. These counsellors were the 
earliest accompanateurs or patient advocates 
and the forerunners of the community care 
workers we have in our primary health 
programme today. Elaine Dube, one of the 
earliest and as passionate today, went on 
to become involved in the very successful 
antenatal care Mothers2mothers programme. 
Initially we started with a ratio of one 
therapeutic counsellor to every ten patients. 
Community-based, they worked in the areas 
where they lived, knew their ‘assigned’ 
patients personally, and were highly effective 
for many reasons: two important ones being 
their deep understanding of their condition 
and the impact of ART in their own lives, 
and the intense empathy that they offered, 
living openly with their own infection at a 
time when HIV was highly stigmatised. Today 
they remain the cornerstone of the success 
of the clinic and it is well accepted that any 
community-based ART programme requires 
community-based support. 
HIV/TB co-infection
Early on in the introduction of ART at HCTC, 
TB was recognised as the leading serious 
opportunistic disease, with more than half of 
patients receiving treatment for TB at the time 
that they started ART. This not only caused 
much suffering for affected patients, but 
patients with TB also had a doubled mortality 
risk compared with those without TB.[3] 
However, the problem was compounded 
by the difficulty in diagnosing TB in patients 
with HIV. We found that only 25% of patients 
with sputum culture-positive pulmonary 
TB reported having a chronic cough for 
longer than 2 weeks. Moreover, we described 
how sputum smear microscopy and chest 
X-rays are able to diagnose only a small 
fraction of the disease present; in turn, one-
fifth of unselected patients not receiving TB 
treatment at the time of first enrolment in the 
clinic actually have sputum culture-positive 
TB, and this has led to much greater use of 
culture-based diagnosis.
Our studies have shown that patients who 
have HIV and TB face great challenges in 
receiving optimum and timely care when ART 
and TB treatment services are not integrated. In 
particular, ART is often unacceptably delayed. 
It has therefore been a huge step forward that, 
from 2011 onwards, patients have been able to 
receive TB treatment at the HCTC, and from 
2012, multidrug-resistant (MDR)-TB patients 
have also been treated on site. We have further 
been able to show that increases in CD4+ 
counts during ART are associated with major 
reductions in long-term TB risk. 
Pregnancy
Programmes for the prevention of mother-
to-child transmission (PMTCT) of HIV were 
introduced at the Midwife Obstetric Unit 
(MOU) at the Gugulethu Community Health 
Clinic in 2001. With an antenatal care HIV 
prevalence rate of 29% in Gugulethu, pregnant 
women constituted a significant proportion 
of the patients who were eligible for ART. 
Work at the HCTC intensified to develop a 
‘fast track’ system that would ensure a quicker 
route to ART commencement for pregnant 
and sick patients. In 2010, the Desmond Tutu 
HIV Foundation ran a pilot programme in 
partnership with the Western Cape Depart-
ment of Health, demonstrating that it was 
safe, feasible and acceptable to initiate women 
whose CD4+ counts were <350 cells/ μl on 
the same day as their diagnosis during the 
first antenatal care visit, and that by doing 
so transmission rates could drop to as low 
as <1%. [4] This approach is now standard 
in the MOU as part of growing emphasis 
on providing rapid ART, and ongoing care 
and support to HIV-positive women during 
pregnancy and post partum. 
Adolescents
A review of the programme’s outcomes 
confirmed what many first-world HIV pro-
grammes and other chronic disease clinical 
services were showing: that adolescents 
often experience a turbulent transitional 
developmental phase and may experience 
significant challenges in traditional ART 
programmes. Despite growing up in the clinic The Sizophila choir. 
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as model patients, older children often lose their VL control and find it 
difficult to adhere and attend services as they move into the teen years. 
In 2005, the HCTC recognised the need to be sensitive to adolescent 
needs, and organised patients aged 10 - 22 years into four age bands to 
attend clinic appointments in their specific age strata. These age-specific 
clinics were held in the afternoons with dedicated youth-oriented 
counsellors and a fun ‘chill room’ within the clinic. It is recognised that 
many of the adolescents are now growing into adulthood and from 2012 
the clinic developed a Health Care Transition model to facilitate the 
shift from adolescent to adult services. 
The future
The HCTC was one of the pioneers of community-based ART in South 
Africa. The early provincial and national treatment protocols, as well 
as a score of subsequent policies and models, have emanated from 
this centre. The lessons learnt have been captured in peer-reviewed 
publications, which have in turn influenced the treatment programmes 
and policies, not only in South Africa, but in many treatment 
programmes throughout Africa and further afield.
The Centre has become an example of what can be achieved through 
a public-private-academic partnership whereby, via careful application of 
a variety of resources – financial, logistical, expertise and innovation – in 
a climate of shared partnership and collaboration, much can be ‘learnt 
by doing’. In a nationwide, public sector health intervention such as the 
South African ART programme, it is critical that specific facilities and 
services are maintained, where critical thinking, rigorous evaluation and 
innovation can be applied to ensure that, in an evolving and dynamic 
epidemic, the best health models and programmes are being utilised. 
The HCTC has, over the last 12 years, not only screened over 10 000 
women, men and children for the need for life-saving ART, it has in 
many ways reached much further to advocate for, instruct, change 
and improve the way in which antiretrovirals are administered on this 
continent and beyond. Importantly, this clinic – with its strong emphasis 
on patient education, patient support and mutual respect – epitomised 
the paradigm of the patient-centred approach that became the hallmark 
of HIV management. Our hope is that these lessons will continue to be 
learnt and written about as we enter the next decade in which we hope the 
flames of the HIV epidemic will be doused and we will see our patients 
growing older in good health. 
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‘ ... it is recognised that many 
of the adolescents are now 
growing into adulthood and 
from 2012 the clinic developed 
a Health Care Transition model 
to facilitate the shift from 
adolescent to adult services.’
